← Leaderboards
Patricia L Musolino
Massachusetts General Hospital
$5,642,292
Attributed
$8,275,404
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,275,404 · 4
By mechanism
R01$4,747,032 · 2
RF1$2,481,348 · 1
K08$1,047,024 · 1
Top collaborators
- Mark E Lindsay4 shared
- Douglas Gould1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Eng H. Lo$32,456,318
- Mingming Ning$8,518,949
- Ken Arai$9,570,276
- Michael A Moskowitz$13,795,692
- Michael J Whalen$16,701,509
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainMolecularPhenotypeGenesCerebrumAffectMutationAnimal ModelCessation Of LifeBiological ModelsMortalityLeadPreventAdrenoleukodystrophyCell ModelPericytesMediatingGene TargetingEndotheliumLaboratoriesBlood - Brain Barrier AnatomyCellsHeterozygoteProteins
Grant awards (16)
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2025 · NS · contact PI
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2024 · NS · contact PI
Effects of ABCD1 Deficiency on Endothelial Function and Permeability to Leukocytes in Cerebral X-linked Adrenoleukodystrophy$382,956
R01 · FY2024 · NS · contact PI
Gene therapy for disorders of the extracellular matrix$2,481,348
RF1 · FY2023 · NS
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2023 · NS · contact PI
Effects of ABCD1 Deficiency on Endothelial Function and Permeability to Leukocytes in Cerebral X-linked Adrenoleukodystrophy$394,800
R01 · FY2023 · NS · contact PI
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2022 · NS · contact PI
Effects of ABCD1 deficiency on endothelial function and permeability to leukocytes in Cerebral X-linked Adrenoleukodystrophy$394,800
R01 · FY2022 · NS · contact PI
Effects of ABCD1 deficiency on endothelial function and permeability to leukocytes in Cerebral X-linked Adrenoleukodystrophy$394,800
R01 · FY2021 · NS · contact PI
Effects of ABCD1 deficiency on endothelial function and permeability to leukocytes in Cerebral X-linked Adrenoleukodystrophy$394,800
R01 · FY2020 · NS · contact PI
Effect of ABCD1 upon Brain Endothelium in X-linked Adrenoleukodystrophy$53,930
K08 · FY2020 · NS · contact PI
Effect of ABCD1 upon Brain Endothelium in X-linked Adrenoleukodystrophy$199,040
K08 · FY2019 · NS · contact PI
Effect of ABCD1 upon Brain Endothelium in X-linked Adrenoleukodystrophy$203,040
K08 · FY2018 · NS · contact PI
Effect of ABCD1 upon Brain Endothelium in X-linked Adrenoleukodystrophy$203,040
K08 · FY2017 · NS · contact PI
Effect of ABCD1 upon Brain Endothelium in X-linked Adrenoleukodystrophy$193,447
K08 · FY2016 · NS · contact PI
Effect of ABCD1 upon Brain Endothelium in X-linked Adrenoleukodystrophy$194,527
K08 · FY2015 · NS · contact PI